��������

Erik DeGenova is a Business Development Executive with over 25 years of experience in the biotechnology and pharmaceutical industry. They have held various roles, including Account Manager and Director of Business Development, across notable companies such as MilliporeSigma, Charles River Laboratories, and Lonza, focusing on a range of services from genetic toxicology to GMP testing. Currently, Erik serves as the Director of Business Development and Strategic Partnerships at MedTherapy Biotech. Erik's academic background includes a Bachelor of Science in Genetics and Neurobiology from Cornell University, where they also contributed as a Research Assistant.